Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

N. Hadar · SciRah

Researcher profile · Semantic Scholar

N. Hadar

Share profile

N. Hadar — researcher profile on SciRah

h-index: 14
Works: 83
Citations: 829

Most-cited papers

Table 2, American Society of Anesthesiologists (ASA) physical status classification system
E. Balk, A. Earley, N. Hadar, Nirav Shah +1 more
2014161 citations
Semantic Scholar
Management Strategies for Asymptomatic Carotid Stenosis
G. Raman, D. Moorthy, N. Hadar, I. Dahabreh +5 more
2013Annals of Internal Medicine129 citations Open access
Semantic Scholar
Innovations in Data Collection, Management, and Archiving for Systematic Reviews
Tian-Jing Li, S. Vedula, N. Hadar, Christopher Parkin +2 more
2015Annals of Internal Medicine93 citations
Semantic Scholar
Asymptomatic Carotid Artery Stenosis Treated with Medical Therapy Alone: Temporal Trends and Implications for Risk Assessment and the Design of Future Studies
N. Hadar, G. Raman, D. Moorthy, T. O'Donnell +5 more
2014Cerebrovascular Diseases69 citations Open access
Semantic Scholar
Accuracy of Data Extraction of Non-English Language Trials with Google Translate
E. Balk, M. Chung, N. Hadar, Kamal Patel +3 more
201265 citations
Semantic Scholar
A Web-based archive of systematic review data
S. Ip, N. Hadar, S. Keefe, Christopher Parkin +3 more
2012Systematic Reviews64 citations Open access
Semantic Scholar
Symptom clusters and physical function for patients receiving chemotherapy.
B. Given, C. Given, A. Sikorskii, N. Hadar
2007Seminars in Oncology Nursing51 citations
Semantic Scholar
The Lack of Evidence for PET or PET-CT Surveillance of Patients with Treated Lymphoma, Colorectal Cancer, and Head and Neck Cancer: A Systematic Review
Kamal Patel, N. Hadar, Jounghee Lee, B. Siegel +2 more
2013Journal of Nuclear Medicine35 citations Open access
Semantic Scholar
Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease
M. Chung, Jeffrey A. Chan, D. Moorthy, N. Hadar +3 more
201230 citations
Semantic Scholar
Emerging Magnetic Resonance Imaging Technologies for Musculoskeletal Imaging Under Loading Stress: Scope of the Literature
I. Dahabreh, N. Hadar, Chun-Shou Mei
2011Annals of Internal Medicine29 citations
Semantic Scholar
Combined immunotherapy with controlled Interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: an open-label, multi-institutional phase 1 trial.
E. Chiocca, A. Gelb, Clark C. Chen, Ganesh Rao +20 more
2021Neuro-Oncology18 citations Open access
Semantic Scholar
Benefits and Harms of Routine Preoperative Testing: Comparative Effectiveness
E. Balk, A. Earley, N. Hadar, Nirav Shah +1 more
201418 citations
Semantic Scholar
Emerging MRI Technologies for Imaging Musculoskeletal Disorders Under Loading Stress
Mei Chung, I. Dahabreh, N. Hadar, Sara J. Ratichek +3 more
201117 citations
Semantic Scholar
Study Flow Diagram
G. Raman, G. Kitsios, D. Moorthy, N. Hadar +5 more
201215 citations
Semantic Scholar
A Community Consultation Survey to Evaluate Support for and Success of the IMMEDIATE Trial
J. Beshansky, Patricia R. Sheehan, Kenneth J. Klima, N. Hadar +2 more
2014Clinical Trials10 citations Open access
Semantic Scholar
Management of Asymptomatic Carotid Stenosis
G. Raman, G. Kitsios, D. Moorthy, N. Hadar +5 more
20126 citations
Semantic Scholar
frontMIND: A phase III, randomized, double-blind study of tafasitamab + lenalidomide + R-CHOP versus R-CHOP alone for newly diagnosed high-intermediate and high-risk diffuse large B-cell lymphoma.
U. Vitolo, G. Nowakowski, J. Burke, C. Fox +6 more
2022Journal of Clinical Oncology4 citations
Semantic Scholar
CTIM-20. FINAL RESULTS OF CONTROLLED IL-12 MONOTHERAPY AND IN COMBINATION WITH PD-1 INHIBITOR IN ADULT SUBJECTS WITH RECURRENT GLIOBLASTOMA
R. Lukas, N. Oberheim-Bush, R. Cavaliere, J. Landolfi +13 more
2021Neuro-Oncology4 citations Open access
Semantic Scholar
Controlled IL-12 in combination with a PD-1 inhibitor subjects with recurrent glioblastoma.
E. Chiocca, R. Lukas, Clark C. Chen, G. Rao +10 more
20203 citations
Semantic Scholar
Supplementary Material for: Asymptomatic Carotid Artery Stenosis Treated with Medical Therapy Alone: Temporal Trends and Implications for Risk Assessment and the Design of Future Studies
N. Hadar, G. Raman, D. Moorthy, T. O'Donnell +5 more
20172 citations
Semantic Scholar
Management Strategies for Asymptomatic Carotid Stenosis
G. Raman, D. Moorthy, N. Hadar, I. Dahabreh +5 more
20132 citations
Semantic Scholar
Proposed Governance and Data Management Policy for the Systematic Review Data Repository
J. Lau, N. Hadar, R. Iovin, S. Ip +1 more
20122 citations
Semantic Scholar
Pharmacokinetics (PK) and pharmacodynamics (PD) in First-MIND: A phase Ib, open-label, randomized study of tafasitamab (tafa) ± lenalidomide (LEN) in addition to R-CHOP in patients (pts) with newly diagnosed diffuse large B-cell lymphoma (DLBCL).
D. Belada, K. Kopeckova, J. B. Bergua Burgues, D. Stevens +7 more
2022Journal of Clinical Oncology1 citations
Semantic Scholar
ABCL-022 Pharmacokinetics and Pharmacodynamics in First-MIND: A Phase Ib, Open-Label, Randomized Study of Tafasitamab ± Lenalidomide + R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma.
D. Belada, K. Kopeckova, Juan Miguel Bergua Burgués, D. Stevens +7 more
2022Clinical Lymphoma, Myeloma & Leukemia1 citations
Semantic Scholar
CTIM-27. PHASE I/II STUDY OF CONTROLLED IL-12 AS IMMUNOTHERAPY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
S. Goldman, S. Mueller, S. Chi, A. Saratsis +9 more
20201 citations Open access
Semantic Scholar
Survival of subjects with recurrent glioblastoma receiving intratumoral administration of controlled IL-12 with limited exposure to dexamethasone.
R. Lukas, Sylvia C. Kurz, John S. Yu, J. Landolfi +11 more
20201 citations
Semantic Scholar
Final results of controlled IL-12 monotherapy in adults with grade III or IV gliomas.
E. Chiocca, R. Lukas, John S. Yu, B. Yamini +11 more
20201 citations
Semantic Scholar
A Structured Approach Using the Systematic Review Data Repository (SRDR)
A. Bonardi, Christine J. Clifford, N. Hadar
2017Evaluation review1 citations
Semantic Scholar
To What Extent Does the Perceived Obesity Level of Humanoid Robots Affect People's Trust in Them?
Yoav Yoscovich, Amir Schreiber, N. Hadar, Reuth Mirsky
2024arXiv.org0 citations
Semantic Scholar
ABCL-023 frontMIND: A Phase III, Randomized, Double-Blind Study of Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP Alone for Newly Diagnosed High-Intermediate and High-Risk Diffuse Large B-Cell Lymphoma.
U. Vitolo, G. Nowakowski, J. Burke, C. Fox +6 more
2022Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
CTIM-05. COMBINATION OF CONTROLLED INTERLEUKIN-12 GENE THERAPY WITH IMMUNE CHECKPOINT BLOCKADE IN RECURRENT GLIOBLASTOMA: UPDATED RESULTS OF A MULTI-INSTITUTIONAL, OPEN LABEL PHASE 1 TRIAL
E. Chiocca, R. Lukas, Clark C. Chen, G. Rao +10 more
20200 citations Open access
Semantic Scholar
CTIM-28. PHASE 2 TRIAL OF CONTROLLED IL-12 IN COMBINATION WITH PD-1 INHIBITOR IN ADULT SUBJECTS WITH RECURRENT GLIOBLASTOMA (rGBM)
R. Lukas, E. Chiocca, N. Bush, J. Landolfi +11 more
20200 citations Open access
Semantic Scholar
List of Rejected Articles
E. Balk, A. Earley, N. Hadar, Nirav Shah +1 more
20140 citations
Semantic Scholar
Risk of Bias
E. Balk, A. Earley, N. Hadar, Nirav Shah +1 more
20140 citations
Semantic Scholar
Table 6, Topics outside scope of Future Research Needs project
M. Chung, Jeffrey A. Chan, D. Moorthy, N. Hadar +3 more
20130 citations
Semantic Scholar
Future Research Needs Process
M. Chung, Jeffrey A. Chan, D. Moorthy, N. Hadar +3 more
20130 citations
Semantic Scholar
Yield of Ongoing Studies
M. Chung, Jeffrey A. Chan, D. Moorthy, N. Hadar +3 more
20130 citations
Semantic Scholar
Effective Health Care Program Selection Criteria
M. Chung, Jeffrey A. Chan, D. Moorthy, N. Hadar +3 more
20130 citations
Semantic Scholar
[Table, Yield of Ongoing Studies].
M. Chung, Jeffrey A. Chan, D. Moorthy, N. Hadar +3 more
20130 citations
Semantic Scholar
Figure 3, Histograms of the percent agreement for descriptions of treatment and control items, by language
E. Balk, M. Chung, N. Hadar, Kamal Patel +3 more
20120 citations
Semantic Scholar
Carotid stenosis data extraction form
G. Raman, G. Kitsios, D. Moorthy, N. Hadar +5 more
20120 citations
Semantic Scholar
SRDR Governance and Data Management
J. Lau, N. Hadar, R. Iovin, S. Ip +1 more
20120 citations
Semantic Scholar
Figure 6, Histograms of the percent agreement for descriptions of outcomes items, by language
E. Balk, M. Chung, N. Hadar, Kamal Patel +3 more
20120 citations
Semantic Scholar
Figure 1, Histograms of the percent agreement for all items, by language
E. Balk, M. Chung, N. Hadar, Kamal Patel +3 more
20120 citations
Semantic Scholar
Baseline characteristics and results of included studies
G. Raman, G. Kitsios, D. Moorthy, N. Hadar +5 more
20120 citations
Semantic Scholar
Forest plot of medical therapy alone studies
G. Raman, G. Kitsios, D. Moorthy, N. Hadar +5 more
20120 citations
Semantic Scholar
Test Performance of Newer Markers for Assessing Iron Status as Defined by Classical Laboratory Markers
M. Chung, D. Moorthy, N. Hadar, Priyanka Salvi +2 more
20120 citations
Semantic Scholar
Table 1, Percentage of studies from Medline in various languages
E. Balk, M. Chung, N. Hadar, Kamal Patel +3 more
20120 citations
Semantic Scholar
[Figure, Annotated Data Extraction Forms].
E. Balk, M. Chung, N. Hadar, Kamal Patel +3 more
20120 citations
Semantic Scholar
Table 6, Items with at least 80 percent agreement, by language and data extraction form section
E. Balk, M. Chung, N. Hadar, Kamal Patel +3 more
20120 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Lau×18
Invite
J. Lau — researcher profile on SciRah
D. Moorthy×16
Invite
D. Moorthy — researcher profile on SciRah
E. Balk×14
Invite
E. Balk — researcher profile on SciRah
M. Chung×14
Invite
M. Chung — researcher profile on SciRah

×12

Invite

T. Trikalinos — researcher profile on SciRah

I. Dahabreh×11

Invite

I. Dahabreh — researcher profile on SciRah

Invite

G. Raman — researcher profile on SciRah

Invite

G. Kitsios — researcher profile on SciRah

T. O'Donnell×8

Invite

T. O'Donnell — researcher profile on SciRah

Invite

E. Feldmann — researcher profile on SciRah

Invite

Kamal Patel — researcher profile on SciRah

Invite

J. Buck — researcher profile on SciRah